MACC1 and colorectal carcinoma: Targeting MACC1 expression in CRC cells with the transcriptional inhibitors rottlerin and lovastatin significantly reduced metastasis formation to the liver in animal models (17), and gave rise to the idea to also combat MACC1-modulated multi-drug resistance in CRC.